Cleveland Clinic Nephrology Update 2026

Cleveland Clinic Nephrology Update 2026 is designed to provide a comprehensive review of the most up-to-date scientific data and analyze its implications for clinical practice. The program focuses on recent and emerging topics that directly impact day-to-day patient care. Led by expert faculty, the course addresses diagnostic and management strategies for patients with various kidney diseases, covering areas such as hypertension, cardio-kidney-metabolic syndrome, cystic kidney diseases, glomerular diseases, and vasculitis.
Learning Objectives
Upon completion of this activity, participants will be able to:

Describe advances in the management of ADPKD and other cystic kidney diseases and review their impact on clinical practice.

Provide an update on the pathogenesis and treatment of various glomerular diseases including IgA nephropathy, anti-GBM disease, ANCA-associated glomerulonephritis, lupus nephritis, thrombotic microangiopathy, and APOL1 nephropathy.

Summarize the safety and efficacy of newer therapies for hypertension, including renal denervation, aldosterone synthase inhibitors, endothelin receptor agonists, and hepatic angiotensinogen silencing RNA, and describe their use in clinical practice, especially for resistant hypertension.

Evaluate the latest evidence-based treatment strategies for hepato-renal and cardio-renal syndromes.

Highlight updated approaches to managing kidney-related complications in cancer patients, including the nephrotoxic effects of immune checkpoint inhibitors and targeted cancer therapeutics.

Target Audience

This activity is designed for nephrologists, cardiologists, intensive care specialists, internists, nurses, nurse practitioners, physician assistants, and other practicing health care professionals who desire an update on recent advancements in chronic kidney disease management and treatment strategies.
Best for Nephrologists, Cardiologists, Critical Care Physicians, Oncologists, and Palliative Medicine Specialists.

Topics

Mineral Bone Disease in CKD

Metabolic Acidosis in CKD

Saving Kidneys, Hearts, and Lives_ Understanding Cardiovascular-Kidney-Metabolic Syndrome

Hyperkalemia and RAAS Inhibitors_ Saving Kidneys, Hearts, and Lives

GLP-RA and the Kidneys_ a Nephrologist Perspective

Cardiovascular Risk Reduction and Hyperlipidemia Management in CKD

ADPKD Update

Non-ADPKD Cystic Kidney Disease Cases

Case Discussions in ADPKD

Journal Club_1

Journal Club_2

APOL1 Nephropathy

Precision Medicine in Glomerular Diseases _ Neptune Match

Update on ANCA Disease_ Reducing the Steroid Burden

IgA Nephropathy_ Update on Pathogenesis and Treatment

Complement Across Glomerular Diseases

Clinicopathologic Case Discussions

Introduction_ Kasperzak Talk

Kasperzak Talk Anti-GBM Disease_ A State of the Art Update

Future Directions in Lupus Nephritis Management

Select Cases from the CCF GN Clinic

Thrombotic Microangiopathy_ a-HUS and Beyond

Clinicopathologic Case Discussions

Hypertension Guidelines Update

Update on Hyperaldosteronism

Practical Approach to Resistant Hypertension

Medical Therapy in Hypertension_ An Evolving Landscape

Update on Renal Denervation

Innovations in BP Measurement

Updates in Hepato-Renal Syndrome

Cardio-Renal Syndrome

AKI in Cancer

AKI in the ICU

Palliative Medicine Workshop_1

Palliative Medicine Workshop_2

Session I_ Cardiovascular Kidney Metabolic Syndrome, Part I

Session II_ Cardiovascular Kidney Metabolic Syndrome, Part II

Session III_ Cystic Kidney Diseases

Session IV_ Journal Club

Session V_ Glomerular Disease Update, Part I

Session VI_ Glomerular Disease Update, Part II

Session VII_ Glomerular Disease Update, Part III

Session VIII_ Glomerular Disease Update, Part IV

Session IX_ Hypertension Updates, Part I

Session X_ Hypertension Updates, Part II

Session XI_ AKI in Special Populations, Part I

Session XII_ AKI in Special Populations, Part II